查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1507987

2033年全球輔助生殖技術市場、機會與策略

Assisted Reproductive Technology Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 393 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2018年全球輔助生殖技術（ART）市場價值為286.24億美元，到2023年複合年成長率將超過5.0%。

多囊性卵巢症候群（PCOS）盛行率增加

PCOS（卵巢症候群）的高盛行率支持了績效期間輔助生殖技術市場的成長。多囊性卵巢症候群是一種發生在育齡婦女身上的荷爾蒙失調。它是有卵巢的育齡人群中最常見的內分泌（荷爾蒙）疾病，保守估計影響 5-10% 的人口。 ART 為 PCOS 患者提供量身定做的治療方案，解決與 PCOS 相關的特定生殖挑戰，並增加成功懷孕和懷孕的機會。體外受精是一種更先進的 ART治療方法，包括從卵巢中取出卵子，在實驗室中用精子使卵子受精，然後將所得胚胎植入子宮。 PCOS 是女性不孕的主要原因之一，估計佔「無排卵」（無排卵）不孕症病例的 80%。體外受精是提高多囊性卵巢症候群女性生育能力最常見的治療方法之一。此外，根據瑞士專門機構世界衛生組織的數據，全球約有 1.16 億女性 (3.4%) 受到多囊性卵巢症候群的影響。因此，PCOS病例的上升帶動了歷史時期輔助生殖技術市場的成長。

目錄

第1章執行摘要

  • 輔助生殖技術 - 市場吸引力和宏觀經濟狀況

第2章 目錄

第3章表格一覽

第4章圖表一覽

第5章 報告結構

第6章市場特點

  • 一般市場定義
  • 概述
  • 輔助生殖技術市場定義與細分
  • 市場區隔：按技術
    • 體外受精（IVF）
    • 人工授精（AI-IUI）
    • 其他技術
  • 市場區隔：按程序類型
    • 新鮮的非捐贈者
    • 新捐款者
    • 冷凍供體
    • 冷凍非捐贈者
    • 胚胎或卵子儲存
  • 市場區隔：按最終用戶
    • 醫院
    • 不孕不育治療診所
    • 其他最終用戶
  • 市場區隔診斷：通過測試
    • 排卵測試
    • 造影
    • 卵巢儲備測試
    • 基因檢測
    • 其他測試

第7章 主要市場趨勢

  • 主要企業推出創新計劃以推進 ART 並支持永續性
  • 人工智慧對輔助生殖技術的影響
  • 輔助生殖技術先進技術解決方案
  • 區塊鏈在輔助生殖技術中的整合
  • 策略合作推動輔助生殖技術創新
  • 透過創新的不孕症治療方案改善獲得醫療保健的機會

第8章輔助生殖科技市場：宏觀經濟情景

  • COVID-19 的影響：輔助生殖技術市場
  • 烏克蘭戰爭的影響：輔助生殖技術市場
  • 高通膨的影響：輔助生殖科技市場

第9章世界市場規模與成長

  • 市場規模
  • 2018-2023 年市場成長表現
    • 2018-2023年市場促進因素
    • 2018-2023年市場限制因素
  • 2023-2028 年、2033 年市場成長預測
    • 2023-2028年市場促進因素
    • 2023-2028年市場限制因素

第10章全球輔助生殖技術市場：細分

  • 全球輔助生殖科技市場：依科技分類的表現與預測，2018-2023、2028、2033
  • 全球輔助生殖技術市場：依手術類型分類的實際狀況與預測，2018-2023、2028、2033
  • 全球輔助生殖技術市場：最終用戶的表現和預測，2018-2023、2028、2033
  • 輔助生殖技術檢測市場（ART檢測/診斷）、表現及預測，2018-2023年、2028年、2033年
    • 全球其他測試市場：ART 測試/診斷的表現和預測，2018-2023、2028、2033

第11章輔助生殖技術市場：區域與國家分析

  • 全球輔助生殖技術市場：按地區分類的表現與預測，2018-2023、2028、2033
  • 全球輔助生殖技術市場：依國家分類的表現與預測，2018-2023、2028、2033

第12章亞太市場

第13章西歐市場

第14章 東歐市場

第15章 北美市場

第16章 南美洲市場

第17章 中東市場

第18章 非洲市場

第19章 競爭格局及公司概況

  • Vitrolife AB
  • Ferring BV
  • Progyny Inc.
  • CooperSurgical Inc.
  • FUJIFILM Irvine Scientific, Inc.

第20章 競爭基準化分析

第 21 章競爭對手儀表板

第22章 重大併購

  • Hamilton Thorne Acquired Gynetics Medical Products
  • Reproductive Medicine Associates（RMA）And IVI-RMA Acquired Conceptions Reproductive Associates of Colorado
  • BPEA EQT Acquired Indira IVF
  • Calibre Scientific Acquired Microm UK Limited And Scopescreen
  • Liverpool Partners Acquired Genea Ltd.

第23章機遇與策略

  • 2028年全球輔助生殖科技市場：提供新機會的國家
  • 2028年全球輔助生殖科技市場：提供新機會的細分市場
  • 2028 年全球輔助生殖技術市場：成長策略
    • 基於市場趨勢的策略
    • 競爭策略

第24章輔助生殖技術市場：結論與建議

  • 結論
  • 推薦
    • 產品
    • 地方
    • 價格
    • 晉升
    • 人們

第25章附錄

簡介目錄
Product Code: o&s1246

Assisted reproductive technology (ART) refers to fertility treatments and procedures that involve the manipulation of eggs, sperm or embryos to increase the likelihood of a successful pregnancy in humans. ART includes all fertility treatments in which either the eggs or the embryos are handled.

The assisted reproductive technology (ART) market consists of sales, by entities (organizations, sole traders and partnerships), of assisted reproductive technology (ART) procedures that are used for the treatment of infertility.

The global assisted reproductive technology (ART) market was valued at $28,624.0 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 5.0%.

Increasing Prevalence Of PCOS

The high prevalence of PCOS (polycystic ovary syndrome) condition supported the assisted reproductive technology market growth in the historic period. PCOS is a hormonal disorder that occurs in women of reproductive age. It is the most common endocrine (hormone) disorder in reproductive-age people with ovaries, affecting, conservatively, 5-10% of that population. ART offers tailored treatment options for individuals with PCOS, addressing the specific reproductive challenges associated with the condition and increasing the likelihood of successful conception and pregnancy. IVF is a more advanced ART procedure that involves the retrieval of eggs from the ovaries, fertilization with sperm in a laboratory setting, and transferring resulting embryos into the uterus. PCOS is one of the leading causes of female infertility, responsible for an estimated 80% of "anovulatory" (no ovulation) infertility cases. IVF is one of the most common treatments for women to increase fertility in women with PCOS. Furthermore, according to WHO, a Switzerland-based specialized agency, approximately 116 million women (3.4%) are affected by PCOS globally. Therefore, increased cases of PCOS drove the assisted reproductive technology market growth in the historic period.

Impact Of Artificial Intelligence On Assisted Reproductive Technology

Several key players operating in the assisted reproductive technology market are integrating efforts to introduce technological innovations, such as artificial intelligence (AI) software, to advance IVF treatment outcomes and lower the costs of the treatment. In IVF, AI algorithms analyze vast amounts of data from patient medical records, lab tests and imaging studies to identify patterns and make predictions. For instance, in October 2022, Alife, a US-based AI-based health technology firm, launched new artificial intelligence software to help fertility clinics optimize and support clinical decision-making during critical stages of the IVF process. Alife uses AI and significant U.S. IVF data sets to examine millions of patient cycle data points. The company's technology can help optimize the IVF treatment process from start to finish by reducing clinic operations and giving patients a more tailored experience.

The global assisted reproductive technology market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 17.9% of the total market in 2022.

Assisted Reproductive Technology Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global assisted reproductive technology market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for assisted reproductive technology? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The assisted reproductive technology market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider assisted reproductive technology market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by diagnosis/testing, by procedure type and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the assisted reproductive technology market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by technology, by diagnosis/testing, by procedure type and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for assisted reproductive technology providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Technology: In Vitro-Fertilization (IVF); Artificial Insemination (AI-IUI); Other Technologies
  • 2) By Procedure Type: Fresh Non-Donor; Fresh Donor; Frozen Donor; Frozen Non-Donor; Embryo or Egg Banking
  • 3) By End-User: Hospitals; Fertility Clinics; Other End-Users
  • 4) By Testing/Diagnosis: In Ovulation Testing; Hysterosalpingography; Ovarian Reserve Testing; Genetic Testing; Other Tests
  • Companies Mentioned: Vitrolife; Ferring B.V.; Progyny Inc.; CooperSurgical Inc.; FUJIFILM Irvine Scientific, Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; assisted reproductive technology indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Assisted Reproductive Technology - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Assisted Reproductive Technology Market Definition And Segmentations
  • 6.4 Market Segmentation By Technology
    • 6.4.1 In Vitro-Fertilization (IVF)
    • 6.4.2 Artificial Insemination (AI-IUI)
    • 6.4.3 Other Technologies
  • 6.5 Market Segmentation By Procedure Type
    • 6.5.1 Fresh Non-Donor
    • 6.5.2 Fresh Donor
    • 6.5.3 Frozen Donor
    • 6.5.4 Frozen Non-Donor
    • 6.5.5 Embryo Or Egg Banking
  • 6.6 Market Segmentation By End-User
    • 6.6.1 Hospitals
    • 6.6.2 Fertility Clinics
    • 6.6.3 Other End-Users
  • 6.7 Market Segmentation By Diagnosis/Testing
    • 6.7.1 Ovulation Testing
    • 6.7.2 Hysterosalpingography
    • 6.7.3 Ovarian Reserve Testing
    • 6.7.4 Genetic Testing
    • 6.7.5 Other Test
      • 6.7.5.1 Computer Assisted Semen Analysis
      • 6.7.5.2 Sperm Penetration Assay
      • 6.7.5.3 Microscopic Examination
      • 6.7.5.4 Others Testing/Diagnosis

7 Major Market Trends

  • 7.1 Key Players Launching Innovative Programs To Promote ART and Support Sustainability
  • 7.2 Impact Of Artificial Intelligence On Assisted Reproductive Technology
  • 7.3 Advanced Technological Solutions In Assisted Reproductive Technology
  • 7.4 Blockchain Integration In Assisted Reproductive Technology
  • 7.5 Strategic Collaborations Driving Innovation In Assisted Reproductive Technology
  • 7.6 Innovative Fertility Treatment Options To Enhance Access To Care

8 Assisted Reproductive Technology Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Assisted Reproductive Technology Market
  • 8.2 Impact Of The War In Ukraine On The Assisted Reproductive Technology Market
  • 8.3 Impact Of High Inflation On The Assisted Reproductive Technology Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Assisted Reproductive Technology Market Segmentation

  • 10.1 Global Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
    • 10.4.1 Global Other Tests Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Assisted Reproductive Technology Market, Regional and Country Analysis

  • 11.1 Global Assisted Reproductive Technology Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Assisted Reproductive Technology Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Assisted Reproductive Technology Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
    • 12.8.1 Market Overview
    • 12.8.2 Country Information
    • 12.8.3 Market Information
    • 12.8.4 Background Information
    • 12.8.5 Government Initiatives
    • 12.8.6 Regulations
    • 12.8.7 Regulatory Bodies
    • 12.8.8 Major Associations
    • 12.8.9 Taxes Levied
    • 12.8.10 Corporate Tax Structure
    • 12.8.11 Investments
    • 12.8.12 Major Companies
  • 12.9 China Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 India Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Market
  • 12.19 Japan Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Japan Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Japan Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Market
  • 12.24 Australia Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Australia Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Australia Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Australia Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Market
  • 12.29 Indonesia Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 Indonesia Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 Indonesia Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 Indonesia Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.33 South Korea Market
  • 12.34 South Korea Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.35 South Korea Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.36 South Korea Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.37 South Korea Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 Western Europe Assisted Reproductive Technology Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 UK Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 UK Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Market
  • 13.13 Germany Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 Germany Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 Germany Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 Germany Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Market
  • 13.18 France Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 France Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 France Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 France Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Italy Market
  • 13.23 Italy Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Italy Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Italy Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.26 Italy Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.27 Spain Market
  • 13.28 Spain Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.29 Spain Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.30 Spain Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.31 Spain Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Assisted Reproductive Technology Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.10 Russia Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.11 Russia Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 North America Assisted Reproductive Technology Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
    • 15.8.1 Market Overview
    • 15.8.2 Country Information
    • 15.8.3 Market Information
    • 15.8.4 Background Information
    • 15.8.5 Government Initiatives
    • 15.8.6 Regulations
    • 15.8.7 Regulatory Bodies
    • 15.8.8 Major Associations
    • 15.8.9 Taxes Levied
    • 15.8.10 Corporate Tax Structure
    • 15.8.11 Investments
    • 15.8.12 Major Companies
  • 15.9 USA Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 USA Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 USA Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Market
  • 15.14 Canada Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Canada Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.17 Canada Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 South America Assisted Reproductive Technology Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.10 Brazil Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.11 Brazil Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Vitrolife AB
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
    • 19.1.3 Business Strategy
    • 19.1.4 Financial performance
  • 19.2 Ferring B.V.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial performance
  • 19.3 Progyny Inc.
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Performance
  • 19.4 CooperSurgical Inc.
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 FUJIFILM Irvine Scientific, Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Hamilton Thorne Acquired Gynetics Medical Products
  • 22.2 Reproductive Medicine Associates (RMA) And IVI-RMA Acquired Conceptions Reproductive Associates of Colorado
  • 22.3 BPEA EQT Acquired Indira IVF
  • 22.4 Calibre Scientific Acquired Microm UK Limited And Scopescreen
  • 22.5 Liverpool Partners Acquired Genea Ltd.

23 Opportunities And Strategies

  • 23.1 Global Assisted Reproductive Technology Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Assisted Reproductive Technology Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Assisted Reproductive Technology Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Assisted Reproductive Technology Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer